经导管主动脉瓣置换术后ST段抬高型心肌梗死的临床特征与结局
该多中心研究纳入118例TAVR术后发生STEMI的患者,并与439例非TAVR的STEMI患者比较。TAVR患者门-球时间更长、PCI失败率更高,院内和中期死亡率分别达25.4%和42.4%,PCI失败、Killip≥2级和eGFR<60与死亡风险增加相关。
要点
- TAVR术后STEMI患者门-球时间延长,PCI失败率高达16.5%。
- 院内死亡25.4%,中期死亡42.4%,预后极差。
- PCI失败、Killip≥2级和eGFR<60是死亡风险增加因素。
核心结论
- TAVR术后STEMI与极高的院内和中期死亡率相关,门-球时间延长和PCI失败率更高部分归因于TAVR患者特有的冠状动脉入路问题,并与更差结局相关。
研究设计与样本
- 多中心研究纳入118例TAVR术后中位255天发生STEMI的患者,并与5个中心同期439例非TAVR的STEMI行直接PCI患者比较。
主要发现
- TAVR患者中位门-球时间40分钟 vs 30分钟(p=0.003),手术时间、透视时间、剂量面积乘积和对比剂用量均更高(p<0.01)。
- TAVR患者PCI失败率16.5% vs 3.9%(p<0.001),其中5例因冠状动脉开口插管失败未血运重建。
- TAVR患者院内死亡25.4%,中期(中位7个月)死亡42.4%;直接PCI患者分别为20.6%和38.2%。
- eGFR<60(HR 3.02;95%CI 1.42-6.43;p=0.004)、Killip≥2级(HR 2.74;95%CI 1.37-5.49;p=0.004)、PCI失败(HR 3.23;95%CI 1.42-7.31;p=0.005)增加死亡风险。
临床怎么用
- 对TAVR术后STEMI患者应优化流程缩短门-球时间,并预判冠状动脉入路困难。
- PCI失败与死亡风险增加相关,需制定应对冠状动脉开口插管失败的策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Among patients with acute coronary syndrome following transcatheter aortic valve replacement (TAVR), those presenting with ST-segment elevation myocardial infarction (STEMI) are at highest risk. OBJECTIVES: The goal of this study was to determine the clinical characteristics, management, and outcomes of STEMI after TAVR. METHODS: This was a multicenter study including 118 patients presenting with STEMI at a median of 255 days (interquartile range: 9 to 680 days) after TAVR. Procedural features of STEMI after TAVR managed with primary percutaneous coronary intervention (PCI) were compared with all-comer STEMI: 439 non-TAVR patients who had primary PCI within the 2 weeks before and after each post-TAVR STEMI case in 5 participating centers from different countries. RESULTS: Median door-to-balloon time was higher in TAVR patients (40 min [interquartile range: 25 to 57 min] vs. 30 min [interquartile range: 25 to 35 min]; p = 0.003). Procedural time, fluoroscopy time, dose-area product, and contrast volume were also higher in TAVR patients (p < 0.01 for all). PCI failure occurred more frequently in patients with previous TAVR (16.5% vs. 3.9%; p < 0.001), including 5 patients in whom the culprit lesion was not revascularized owing to coronary ostia cannulation failure. In-hospital and late (median of 7 months [interquartile range: 1 to 21 months]) mortality rates were 25.4% and 42.4%, respectively (20.6% and 38.2% in primary PCI patients), and estimated glomerular filtration rate <60 ml/min (hazard ratio [HR]: 3.02; 95% confidence interval [CI]: 1.42 to 6.43; p = 0.004), Killip class ≥2 (HR: 2.74; 95% CI: 1.37 to 5.49; p = 0.004), and PCI failure (HR: 3.23; 95% CI: 1.42 to 7.31; p = 0.005) determined an increased risk. CONCLUSIONS: STEMI after TAVR was associated with very high in-hospital and mid-term mortality. Longer door-to-balloon times and a higher PCI failure rate were observed in TAVR patients, partially due to coronary access issues specific to the TAVR population, and this was associated with poorer outcomes.
引用
- Faroux L, Lhermusier T, Vincent F, et al. ST-Segment Elevation Myocardial Infarction Following Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2021. PMID: 33926655. doi:10.1016/j.jacc.2021.03.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。